|
AAK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.13840000000177E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89600000000323E-05 |
| Normal-vs-Stage2 |
4.861600E-01 |
| Normal-vs-Stage3 |
1.437610E-02 |
| Normal-vs-Stage4 |
1.434350E-02 |
| Stage1-vs-Stage2 |
3.017600E-01 |
| Stage1-vs-Stage3 |
6.915200E-01 |
| Stage1-vs-Stage4 |
9.768200E-01 |
| Stage2-vs-Stage3 |
4.584000E-01 |
| Stage2-vs-Stage4 |
4.629800E-01 |
| Stage3-vs-Stage4 |
7.899600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.216250E-04 |
| Normal-vs-AfricanAmerican |
2.422800E-04 |
| Normal-vs-Asian |
5.815100E-03 |
| Caucasian-vs-AfricanAmerican |
6.999200E-01 |
| Caucasian-vs-Asian |
5.503400E-01 |
| AfricanAmerican-vs-Asian |
5.790600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32739999994624E-06 |
| Normal-vs-Female |
2.058600E-01 |
| Male-vs-Female |
5.261200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.658300E-02 |
| Normal-vs-Extreme_Weight |
8.70390004514832E-09 |
| Normal-vs-Obese |
4.387600E-02 |
| Normal-vs-Extreme_Obese |
4.764100E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.358500E-02 |
| Normal_Weight-vs-Obese |
6.939000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.731600E-01 |
| Extreme_Weight-vs-Obese |
9.644600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.286820E-01 |
| Obese-vs-Extreme_Obese |
7.842800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.803300E-03 |
| Normal-vs-Age(41-60Yrs) |
8.167200E-04 |
| Normal-vs-Age(61-80Yrs) |
6.48070000000001E-05 |
| Normal-vs-Age(81-100Yrs) |
8.824000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.194800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.723600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.052200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.736600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.952400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.046400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.94940000003619E-06 |
| Normal-VS-Type2 PRCC |
4.218000E-02 |
| Normal-VS-KIRP CIMP |
4.982200E-01 |
| Normal-VS-Unclassified PRCC |
2.281800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.030640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.645390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.008390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.192400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.087800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.029200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.238900E-04 |
| Normal-vs-N1 |
1.078820E-01 |
| Normal-vs-N2 |
1.728760E-01 |
| N0-vs-N1 |
2.135400E-01 |
| N0-vs-N2 |
6.840000E-01 |
| N1-vs-N2 |
8.578800E-01 |
|
|
